These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31392312)

  • 1. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
    Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Antithrombotic Therapy versus Anticoagulant Monotherapy for Major Adverse Limb Events in Patients with Concomitant Lower Extremity Arterial Disease and Atrial Fibrillation: A Propensity Score Weighted Analysis.
    Lin DS; Wu HP; Chung WJ; Hsueh SK; Hsu PC; Lee JK; Chen CC; Huang HL
    Eur J Vasc Endovasc Surg; 2024 Oct; 68(4):498-507. PubMed ID: 38754724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Use of Anticoagulation or Dual Antiplatelet Therapy for Patients with Extra-anatomic Bypasses.
    Teveris V; Columbo J; Bartline P; Goodney P; Stone D; Suckow B
    Ann Vasc Surg; 2020 Jul; 66():272-281.e1. PubMed ID: 31931126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia.
    Marcaccio CL; Patel PB; Wang S; Rastogi V; Moreira CC; Siracuse JJ; Schermerhorn ML; Stangenberg L
    J Vasc Surg; 2022 May; 75(5):1696-1706.e4. PubMed ID: 35074410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia.
    Rockhold M; Kunkel L; Lacoste JL; Szymanski T; Rothenberg P; Zimmerman P; Minc S
    J Vasc Surg; 2024 Jun; 79(6):1466-1472.e1. PubMed ID: 38278371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta-analysis.
    Atti V; Turagam MK; Garg J; Velagapudi P; Patel NJ; Basir MB; Mujer MT; Rayamajhi S; Abela GS; Koerber S; Gopinnathanair R; Lakkireddy D
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2460-2472. PubMed ID: 31432607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of antiplatelet therapy with clinical outcomes in patients with peripheral artery disease.
    Al-Sadawi M; Tao M; Dhaliwal S; Masson R; Bhagat AA; Parikh PB; Lawson WE; Reilly JP
    Cardiovasc Revasc Med; 2024 May; 62():66-72. PubMed ID: 38176961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Ke Y; Wang J; Wang W; Guo S; Dai M; Wu L; Bao Y; Li B; Ju J; Xu H; Jin Y
    Int J Cardiol; 2022 Sep; 362():139-146. PubMed ID: 35654173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in patients after transcatheter aortic valve implantation: a network meta-analysis.
    Turgeon RD; Ellis UM; Barry AR
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):454-464. PubMed ID: 38081213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
    Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
    J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials.
    Guedeney P; Roule V; Mesnier J; Chapelle C; Portal JJ; Laporte S; Ollier E; Zeitouni M; Kerneis M; Procopi N; Barthelemy O; Sorrentino S; Mihalovic M; Silvain J; Vicaut E; Montalescot G; Collet JP
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):251-261. PubMed ID: 36640149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotics in stable peripheral artery disease.
    Kaplovitch E; Rannelli L; Anand SS
    Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.
    Ji Y; Wang B; Wu G; Zhang Y; Wang Q; Zhou M
    Ther Adv Chronic Dis; 2023; 14():20406223231213262. PubMed ID: 38085917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Rivaroxaban Compared to Acenocumarol after Infrainguinal Surgical Revascularization.
    Ferreira V; Freixo C; Gonçalves J; Teixeira G; Antunes I; Veiga C; Mendes D; Martins J; Almeida R
    Ann Vasc Surg; 2019 Feb; 55():78-84. PubMed ID: 30099168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.
    Kim TI; DeWan A; Murray M; Wang H; Mani A; Mena-Hurtado C; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Aug; 105():150-157. PubMed ID: 38593922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.